Outlook Therapeutics
OTLK
#8163
Rank
โ‚น11.90 B
Marketcap
โ‚น503.36
Share price
0.00%
Change (1 day)
40.81%
Change (1 year)

Revenue for Outlook Therapeutics (OTLK)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Outlook Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A-100%
2019 โ‚น0.50 B114.09%
2018 โ‚น0.23 B-13.89%
2017 โ‚น0.27 B75.79%
2016 โ‚น0.15 B-28.66%
2015 โ‚น0.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น46.13 BN/A Jersey
โ‚น65.84 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.12 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.83 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK